
Last 4 earnings calls · through Q2 FY2026
Globe Life sells simple protection products to an underinsured market through its own agents, so growth depends on recruiting rather than on taking share from rivals.
Medicare Supplement demand is rising as beneficiaries leave Medicare Advantage, and Globe Life is capturing that shift with rate increases regulators have already approved.
Favorable mortality has let management lower reserves several times, which lifts underwriting margins and frees cash for buybacks and dividends.
Liberty National and Family Heritage keep adding agents and sales, which offsets the slower hiring at American Income and broadens the distribution base.
American Income's agent count is shrinking, and the recovery management promises keeps moving later, so life sales lean on productivity gains that may not last.
Paid search is shrinking as consumers turn to AI assistants, pushing direct-to-consumer sales down and raising the cost of the leads that feed the agencies.
Earnings growth leans on actuarial reserve releases management chooses to book, while health margins are squeezed by Medicare Supplement claims and a start-up group unit.
The Bermuda reinsurance affiliate was meant to send cash to the parent, but regulatory approvals keep that benefit in later years and none of it is in current guidance.
In short: Medicare Supplement sales grow fast, while American Income agent counts and life premium fall.
Health segment revenue rose 18% to $437 million in the second quarter, and management credits beneficiaries moving out of Medicare Advantage into Medicare Supplement.
Agent growth at these two agencies is offsetting the decline at American Income, and the new worksite enrollment platform is lifting premium per worksite in early rollouts.
A year ago management cited a 17% rise in new hires; now American Income's agent count is down 7% and the turnaround rests on new manager incentives.
Management expects life premium revenue to grow just 2.5% to 3% this year, as fewer American Income agents and weaker direct-to-consumer sales slow the largest segment.
In short: Cash generation is strong, but health margins are thinner and earnings lean on actuarial reserve releases.
Diluted shares are down 16.6% over three years, and management raised its 2026 buyback range to $670 million to $700 million from $535 million to $585 million.
Lower long-term mortality assumptions cut the reserves needed to back policies, so the same premium now supports a higher underwriting margin and more excess cash flow.
Management expects those items to moderate, but United American's health margin has run below its historical range while that division becomes a larger share of premium.
A year ago an assumption update was a possibility at the top of the range; management now builds $110 million to $130 million of remeasurement gains into guidance.
In short: An underserved market limits competition, while online lead flow and agent classification remain risks.
Management says more than half of Americans are underinsured and its agents reach households other insurers avoid, so growth does not require taking share from a competitor.
The fixed maturity portfolio is rated A- and management reports no commercial mortgage loans on office properties, which limits credit losses if real estate weakens.
A year ago management described a direct-to-consumer sales turnaround; it now calls the channel a transition period as AI search cuts paid-search volume and raises costs.
The EEOC's findings on how American Income agents are classified are not binding and no suit is pending, but litigation would target the model that produces most sales.